Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E M Bonnem

Showing results (1-10 of 16) with videos related to

Pageof 2
Sort By:
Seminars in Oncology|June 1, 1987
Alfa interferon: combinations with other antineoplastic modalitiesE M Bonnem
Investigational New Drugs|January 1, 1987
Alpha interferon: a look to the futureE M Bonnem
European Journal of Cancer (Oxford, England : 1990)|January 1, 1991
alpha Interferon: the potential drug of adjuvant therapy: past achievements and future challengesE M Bonnem
Journal of Biological Response Modifiers|June 1, 1987
Gamma-interferon: physiology and speculation on its role in medicineE M Bonnem, R K Oldham
Cancer Treatment Reports|August 1, 1982
Platinum concentrations in human glioblastoma multiforme following the use of cisplatinE M Bonnem, C L Litterst, F P Smith
Investigational New Drugs|January 1, 1996
Phase I trial of recombinant platelet factor 4 (rPF4) in patients with advanced colorectal carcinomaN Belman, E M Bonnem, H A Harvey, et al.
Leukemia|February 1, 1987
A trial of recombinant alpha 2 interferon in the myelodysplastic syndromes: I. Clinical resultsL Elias, R Hoffman, S Boswell, et al.
Circulation|April 15, 1995
Reversal of heparin anticoagulation by recombinant platelet factor 4 in humansG J Dehmer, M Fisher, D A Tate, et al.
British Journal of Haematology|August 1, 1983
Methotrexate-induced immune haemolytic anaemiaP V Woolley, R A Sacher, V M Priego, et al.
Circulation|November 1, 1996
Randomized trial of recombinant platelet factor 4 versus protamine for the reversal of heparin anticoagulation in humansG J Dehmer, R A Lange, D A Tate, et al.
Pageof 2

Showing results (1-10 of 16) with videos related to

Sort By:
Pageof 2
Seminars in Oncology|June 1, 1987
Alfa interferon: combinations with other antineoplastic modalitiesE M Bonnem
Investigational New Drugs|January 1, 1987
Alpha interferon: a look to the futureE M Bonnem
European Journal of Cancer (Oxford, England : 1990)|January 1, 1991
alpha Interferon: the potential drug of adjuvant therapy: past achievements and future challengesE M Bonnem
Journal of Biological Response Modifiers|June 1, 1987
Gamma-interferon: physiology and speculation on its role in medicineE M Bonnem, R K Oldham
Cancer Treatment Reports|August 1, 1982
Platinum concentrations in human glioblastoma multiforme following the use of cisplatinE M Bonnem, C L Litterst, F P Smith
Investigational New Drugs|January 1, 1996
Phase I trial of recombinant platelet factor 4 (rPF4) in patients with advanced colorectal carcinomaN Belman, E M Bonnem, H A Harvey, et al.
Leukemia|February 1, 1987
A trial of recombinant alpha 2 interferon in the myelodysplastic syndromes: I. Clinical resultsL Elias, R Hoffman, S Boswell, et al.
Circulation|April 15, 1995
Reversal of heparin anticoagulation by recombinant platelet factor 4 in humansG J Dehmer, M Fisher, D A Tate, et al.
British Journal of Haematology|August 1, 1983
Methotrexate-induced immune haemolytic anaemiaP V Woolley, R A Sacher, V M Priego, et al.
Circulation|November 1, 1996
Randomized trial of recombinant platelet factor 4 versus protamine for the reversal of heparin anticoagulation in humansG J Dehmer, R A Lange, D A Tate, et al.
Pageof 2